Clinical Trial

Ketone Monoester Supplements, High Altitude, and Brain Blood Flow During Exercise

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this trial is to investigate the effect of acute ketone monoester ingestion (0.6 g KME/kg body weight) on the occurrence of the ventilatory threshold and the subsequent response of blood velocity in cerebral arteries during a maximal exercise test at low altitude and high altitude.
Trial Details
NCT Number NCT07063732
Lead Sponsor McMaster University
Conditions High Altitude Hypoxia, Exercise
Enrollment 14 participants
Start Date 2025-05-28
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-14